More on lot-to-lot changes

Clinical Chemistry

Volumn 60, Issue 2, 2014, Pages 413-414

  Bais, Renze ^a   Chesher, Douglas ^b  

^a North Royal North Shore Hospital ^*  (United States)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CREATININE; REAGENT; SOMATOMEDIN C; DIAGNOSTIC KIT;

CLINICAL CHEMISTRY; DIAGNOSTIC ERROR; HUMAN; KIDNEY TRANSPLANTATION; LABORATORY TEST; LETTER; PATIENT MONITORING; DIAGNOSTIC KIT; STANDARDS;

HUMANS; INSULIN-LIKE GROWTH FACTOR I; REAGENT KITS, DIAGNOSTIC;

EID: 84893464180     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.215111     Document Type: Letter

References (4)

1. Algeciras-Schimnich A, Bruns DE, Boyd JC, Bryant SC, La Fortune KA, Grebe S K G. Failure of current laboratory protocols to detect lot-to-lot reagent differences: findings and possible solutions. Clin Chem 2013;59:1187-94.
2. Bais R. What information should manufacturers provide on their procedures? Clin Chem 2006;52:1624-5.
3. Bais R, Armbruster D, Jansen R T P, Klee G, Panteghini M, Passarelli J, Sikaris KA. Defining acceptable limits for the metrological traceability of specific measurands. Clin Chem Lab Med 2013;51:973-9.
4. Infusino I, Braga F, Mozzi R, Valente C, Panteghini M. Is the accuracy of serum albumin measurements suitable for clinical application of the test? Clin Chim Acta 2011;412:791-2.